AEON Clinic in Dubai is expanding physician-led IV therapies, particularly NAD+ treatments, to meet growing demand for personalized health optimization. The clinic positions these interventions within longer-term health strategies rather than as standalone wellness experiences, reflecting a broader shift from managing disease to optimizing healthspan.
Key Points
- NAD+ therapies support cellular energy production and repair processes that decline with age
- IV nutrient delivery bypasses digestive barriers for more direct bioavailability than oral supplemen
- Personalized, physician-supervised protocols are becoming standard practice in longevity medicine
Longevity Analysis
This expansion reflects how interventions targeting cellular function are moving from niche biohacking into mainstream medical practice. NAD+ therapy addresses a fundamental mechanism of aging—declining capacity for energy production and cellular regeneration—by working at the level of metabolic infrastructure. The emphasis on physician oversight and individualized assessment matters: without proper diagnostics and monitoring, intravenous nutrient therapies risk becoming superficial wellness theater rather than coherent strategies that account for how a person's digestive capacity, energy production, and stress response systems actually function. The shift toward measuring success by practical outcomes (sustained energy, mental clarity, recovery speed) rather than biomarker changes alone signals maturation in the field, though long-term outcome data remain limited.
Original published by Longevity.Technology, by Kyle Umipig.